Tipranavir and alanine aminotransferase increased Patient Reports February 11, 2012

Tipranavir Side Effects Report #5098984-4
Tipranavir side effect was reported by a Health Professional from FRANCE on Aug 31, 2006. Male patient, 55 years of age, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, dyspepsia, gamma-glutamyltransferase increased, hepatomegaly. Tipranavir dosage: unknown. During the same period patient was treated with NORVIR, DIDANOSINE, ENFUVIRTIDE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5113047-7
Tipranavir side effect was reported by a Health Professional from FRANCE on Aug 31, 2006. Male patient, 55 years of age, weighting 143.3 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, hepatomegaly. Tipranavir dosage: TPV/RTV 500/200 MG B.I.D.. During the same period patient was treated with VIDEX, FUZEON. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4745413-3
Tipranavir side effect was reported by a Physician from UNITED STATES on Aug 09, 2005. Male patient, 40 years of age, weighting 114.4 lb, was diagnosed with hiv infection , pain  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride decreased, blood potassium decreased, blood sodium decreased, carbon dioxide decreased, gamma-glutamyltransferase increased, gastric dilatation. Tipranavir dosage: TPV/R 1000/400MG (SEE TEXT, STRENGTH 250/100 MG), PO. During the same period patient was treated with MORPHINE ERT, COMBIVIR, DIDANOSINE, ENFUVIRTIDE, AMMONIUM LACTATE, AZITHROMYCIN, CITALOPRAM. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5202756-7
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Jan 05, 2007. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, coagulation time prolonged, contusion, microcytic anaemia, prothrombin time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.


Tipranavir Side Effects Report #5219810-6
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Jan 18, 2007. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, antiphospholipid syndrome, arthropod bite, aspartate aminotransferase increased, blood amylase increased, blood lactate dehydrogenase increased, coagulation factor increased, coagulation time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.

Tipranavir Side Effects Report #5225373-1
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Jan 26, 2007. Female patient, weighting 49.01 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthropod bite, aspartate aminotransferase increased, coagulation time prolonged, contusion, injury, microcytic anaemia. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN. Patient recovered.

Tipranavir Side Effects Report #5261131-X
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Mar 06, 2007. Female patient, weighting 49.01 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, coagulation time prolonged, contusion, injury, prothrombin time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN. Patient recovered.

Tipranavir Side Effects Report #5281988-6
Tipranavir side effect was reported by a Consumer or non-health professional from on Feb 22, 2006. Male patient, weighting 156.5 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, pneumonia . Tipranavir dosage: TIPRANAVIR 1000MG+RITONAVIR 400MG. During the same period patient was treated with SUSTIVA. Patient was hospitalized. Patient died on 10/17/2005.

Tipranavir Side Effects Report #5283793-3
Tipranavir side effect was reported by a Consumer or non-health professional from on Feb 22, 2006. Male patient, weighting 156.5 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, pneumonia . Tipranavir dosage: TIPRANAVIR 1000MG+RITONAVIR 400MG. During the same period patient was treated with SUSTIVA. Patient was hospitalized. Patient died on 10/17/2005.


Tipranavir Side Effects Report #5096514-4
Tipranavir side effect was reported by a Consumer or non-health professional from on July 14, 2006. Male patient, weighting 88.18 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: acute abdomen, alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, blood alkaline phosphatase increased, blood glucose decreased, blood lactate dehydrogenase increased, blood sodium decreased, coagulopathy. Tipranavir dosage: 800 MG/320 MG TPV/RTV. Patient was hospitalized. Patient died on 08/05/2006.

Tipranavir Side Effects Report #5165012-1
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Sept 15, 2006. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal injury, activated partial thromboplastin time prolonged, alanine aminotransferase increased, arthropod bite, coagulation time prolonged, contusion, iron deficiency anaemia, prothrombin time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.

Tipranavir Side Effects Report #5169461-7
Tipranavir side effect was reported by a Consumer or non-health professional from ARGENTINA on July 14, 2006. Male patient, weighting 88.18 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, acanthosis, activated partial thromboplastin time prolonged, acute abdomen, alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, bilirubin conjugated increased. Tipranavir dosage: 800 MG/320 MG TPV/RTV. Patient was hospitalized. Patient died on 08/05/2006.

Tipranavir Side Effects Report #5172155-5
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Sept 15, 2006. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal injury, activated partial thromboplastin time prolonged, alanine aminotransferase increased, arthropod bite, aspartate aminotransferase increased, coagulation factor viii level increased, coagulation time prolonged, contusion, prothrombin time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.

Tipranavir Side Effects Report #5186471-4
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Sept 15, 2006. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, coagulation time prolonged, contusion, prothrombin time prolonged. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.


Tipranavir Side Effects Report #5192388-1
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES MINOR OUTLYING ISLANDS on Sept 15, 2006. Female patient, weighting 50.00 lb, was diagnosed with hiv infection , retroviral infection, medical diet, antifungal prophylaxis, antibiotic prophylaxis, increased appetite, mineral supplementation and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, antiphospholipid syndrome, arthropod bite, cd4 lymphocytes decreased, coagulation time prolonged, contusion, injury, iron deficiency. Tipranavir dosage: TPV/RTV 510 MG/202 MG. During the same period patient was treated with ABACAVIR, SIDERAL, FOLIC ACID, BACTRIM, ZITHROMAX, PERIACTIN, CALCIUM GLUCONATE. Patient recovered.

Tipranavir Side Effects Report #5685126-7
Tipranavir side effect was reported by a Consumer or non-health professional from BRAZIL on Mar 27, 2008. Male patient, weighting 116.8 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood bilirubin unconjugated increased, blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased. Tipranavir dosage: TPV/RTV 1000MG/400MG DAILY DOSE. During the same period patient was treated with DIDANOSINE, ABACAVIR. Patient was hospitalized. Patient died on 03/20/2008.

Tipranavir Side Effects Report #4772123-9
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2005. Male patient, weighting 171.1 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gastrointestinal haemorrhage, haematemesis, haematocrit decreased, haemoglobin decreased, nausea , occult blood positive, orthostatic hypotension. Tipranavir dosage: TPV/R 1000/400MG DAILY. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4777870-0
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2005. Male patient, weighting 171.1 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood magnesium decreased, blood potassium decreased, chills, dizziness , dyspnoea, gastrointestinal haemorrhage, gastrointestinal ulcer haemorrhage. Tipranavir dosage: TPV/R 1000/400MG DAILY. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4785619-0
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2005. Male patient, weighting 171.1 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, body temperature increased, gastrointestinal haemorrhage, gastrointestinal ulcer haemorrhage, platelet count decreased, post procedural complication. Tipranavir dosage: TPV/R 1000/400MG DAILY. Patient was hospitalized. Patient recovered.


Tipranavir Side Effects Report #4793601-2
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 26, 2005. Female patient, weighting 122.0 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal discomfort, alanine aminotransferase increased, aspartate aminotransferase increased, blood amylase increased, diarrhoea, hepatic enzyme increased, lipase increased, nausea . Tipranavir dosage: TPV/R 1000/400 MG. During the same period patient was treated with TRUVADA. Patient recovered.

Tipranavir Side Effects Report #4827951-8
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 26, 2005. Female patient, weighting 122.0 lb, was diagnosed with hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal discomfort, alanine aminotransferase increased, aspartate aminotransferase increased, blood amylase increased, diarrhoea, hepatic enzyme increased, lipase increased, nausea , pancreatic enzymes increased. Tipranavir dosage: TPV/R 1000/400 MG. During the same period patient was treated with TRUVADA. Patient recovered.

Tipranavir Side Effects Report #4900051-4
Tipranavir side effect was reported by a Consumer or non-health professional from BRAZIL on Oct 19, 2004. Male patient, weighting 114.9 lb, was diagnosed with hiv infection , neutropenia, prophylaxis, antibiotic prophylaxis, hypertriglyceridaemia and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, diarrhoea, isosporiasis. Tipranavir dosage: TPV/RTV 1000/400 MG. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ, FOLINIC ACID, VITAMIN B CAP, L CARTININE, SULPHAMETHOXAZOLE, BEZAFIBRATE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #4902873-2
Tipranavir side effect was reported by a Consumer or non-health professional from BRAZIL on Oct 19, 2004. Male patient, weighting 114.9 lb, was diagnosed with hiv infection , neutropenia, prophylaxis, antibiotic prophylaxis, hypertriglyceridaemia and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, isosporiasis. Tipranavir dosage: TPV/RTV 1000/400 MG. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ, FOLINIC ACID, VITAMIN B CAP, L CARTININE, SULPHAMETHOXAZOLE, BEZAFIBRATE. Patient was hospitalized. Patient recovered.

Tipranavir Side Effects Report #5326702-0
Tipranavir side effect was reported by a Health Professional from FRANCE on Feb 06, 2007. Male patient, 58 years of age, weighting 202.8 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, anorexia, arthralgia, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, diarrhoea. Tipranavir dosage: unknown. During the same period patient was treated with RITONAVIR, ENFUVIRTIDE, EMTRICITABINE. Patient was hospitalized. Patient recovered.


Tipranavir Side Effects Report #5118889-X
Tipranavir side effect was reported by a Consumer or non-health professional from UNITED STATES on May 14, 2001. Male patient, weighting 222.0 lb, was diagnosed with acquired immunodeficiency syndrome, hiv infection  and was treated with Tipranavir. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, brain stem infarction, cardiac arrest , dehydration, dyspnoea, lactic acidosis, liver function test abnormal, renal failure acute. Tipranavir dosage: TPV/RTV 1250/100MG. During the same period patient was treated with VIRAMUNE, ZERIT, VIDEX. Patient was hospitalized. Patient died on 05/15/2001.